BlackRock Institutional Trust’s CASI Pharmaceuticals CASI Stock Holding History

BlackRock Institutional Trust’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$259K	Hold	22,565	–	–	﹤0.01%	3560
2016 Q3	$250K	Hold	22,565	–	–	﹤0.01%	3591
2016 Q2	$264K	Hold	22,565	–	–	﹤0.01%	3599
2016 Q1	$239K	Hold	22,565	–	–	﹤0.01%	3593
2015 Q4	$217K	Hold	22,565	–	–	﹤0.01%	3641
2015 Q3	$241K	Hold	22,565	–	–	﹤0.01%	3618
2015 Q2	$404K	Hold	22,565	–	–	﹤0.01%	3542
2015 Q1	$333K	Buy	22,565 +151	+0.7%	+$2.38K	﹤0.01%	3572
2014 Q4	$298K	Hold	22,414	–	–	﹤0.01%	3596
2014 Q3	$401K	Buy	+22,414	New	+$399K	﹤0.01%	3524
2014 Q2	–	Sell	-22,414	Closed	-$408K	–	3947
2014 Q1	$408K	Hold	22,414	–	–	﹤0.01%	3604
2013 Q4	$375K	Hold	22,414	–	–	﹤0.01%	3627
2013 Q3	$403K	Sell	22,414 -78	-0.3%	-$1.48K	﹤0.01%	3559
2013 Q2	$454K	Buy	+22,492	New	+$436K	﹤0.01%	3508

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Institutional Trust's CASI Position: Q4 2016 in Review

BlackRock Institutional Trust held its CASI Pharmaceuticals (CASI) position steady in Q4 2016 at 22,565 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #3560.

BlackRock Institutional Trust first reported a position in CASI in Q2 2013 and has held it in 14 quarters since. The position peaked at $454K in Q2 2013. 28 funds tracked by Wall St. Rank hold CASI as of Q4 2016.

BlackRock Institutional Trust held 22,565 shares of CASI Pharmaceuticals worth $259K as of Q4 2016.
BlackRock Institutional Trust left its CASI Pharmaceuticals share count unchanged in Q4 2016.
CASI Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3560 holding.
BlackRock Institutional Trust first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
BlackRock Institutional Trust's CASI Pharmaceuticals position peaked at $454K in Q2 2013.
28 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.